IL2RG and acute lymphoblastic leukemia: This treatment regimen elicited a potent therapeutic response in NOD-SCID-IL2Rγ (NSG) mice bearing near-haploid or diploidized B-ALL cells (Supplementary Figure 3a, upper panels).